Night Blindness (Nyctalopia): Who Is at Risk and Why

Nyctalopia—difficulty seeing in low light—is not a disease but a symptom of underlying conditions. Risk varies by age and health status.

Primary Risk Groups

1. Older Adults

  • Reduced rhodopsin regeneration (visual pigment).
  • Pupillary miosis (smaller pupils) → less light entry.
  • Lens yellowing/cataracts → scatter and filter light.
  • Age-related macular degeneration (AMD) affects central and low-light vision.

2. Children & Adolescents

  • Vitamin A deficiency (leading cause globally) → impaired rhodopsin synthesis.
  • Retinitis pigmentosa (genetic) — night blindness is often the first symptom.
  • Congenital stationary night blindness (CSNB).

3. People with Eye Diseases

  • Cataracts: Lens opacity scatters light.
  • Glaucoma: Peripheral vision loss + medication side effects (miotics).
  • Diabetic retinopathy: Retinal ischemia, macular edema.
  • High myopia: Retinal thinning, degenerative changes.

4. Systemic Conditions

  • Diabetes: Autonomic neuropathy affects pupillary dilation.
  • Zinc deficiency: Impairs vitamin A metabolism.
  • Post-bariatric surgery: Malabsorption of fat-soluble vitamins.

Evaluation

Comprehensive eye exam: visual acuity, refraction, dilated fundus exam, visual fields, electroretinography (ERG) if hereditary cause suspected. Blood tests for vitamin A, zinc, glucose.

Management

  • Treat underlying cause (cataract surgery, vitamin A supplementation, glucose control).
  • Low-vision aids: high-contrast lighting, amber filters, orientation training.
  • Avoid night driving if unsafe.

Sudden onset night blindness requires urgent ophthalmologic assessment.

Eye & Vision Disorders - Related Articles